CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Chief Executive Officer sold 50,000 shares at an average $60.51 ($3,025,573)
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Chief Executive Officer sold 20,000 shares at $62.50 ($1,250,058)
- 144 Insider Sale of Securities
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 8-K Event Material agreement
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 45 · 883 filings